Pharma & Life Sciences

Generic and Biosimilar Medicine Conference (GRx+Biosims)

The Generic and Biosimilar Medicines Conference (GRx+Biosims) is a three-day event focused on regulatory, scientific, and policy issues in the U.S. generics and biosimilars industry.

It is designed for scientists, policy professionals, advocates, regulators, and industry stakeholders to gain insights, network, and learn about the latest developments affecting affordable medicines.

3 months until it opens.

The essentials

Event details

Dates
2 November 2026 to 4 November 2026
Address
5701 Marinelli Rd. Rockville, MD 20852
Organiser
GRx+Biosims
Expected attendance
26
Industry
Pharma & Life Sciences

Who attends

The audience

Policy professionals, advocacy groups, thought leaders and regulators all have the opportunity to network with others in the industry and gain a deeper understanding of how regulations affect the real world.

As described by the organiser

Public discussion

What people are saying

Agenda themes

Topics covered

  • Medical & Pharma

On stage

Speakers

  • Scott Biggs, Director, Supplier Services, IQVIA
  • Bob Hoffman, AAM Board Chair
  • Alex Keeton, AAM
  • John Murphy III, President and CEO, AAM

On the floor

Sponsors and partners

  • U.S. Pharmacopeia
  • Apotex
  • Lupin
  • Zydus USA
  • Dr. Evidence

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.